基本信息
views: 255
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I focused on the management of urological tumors and kidney cancer in particular. I combine high-quality patient care with research. Within our team we study the effects of anticancer drug therapy given either before or after kidney cancer surgery on a national and international level. Our internationally leading research provided me with a multidisciplinary worldwide network of experts ensuring we offer people diagnosed with kidney cancer the best and most innovative care. This applies to the diagnosis, treatment, and follow-up of kidney cancer.
Research Interests
Papers共 646 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL GENITOURINARY CANCERno. 2 (2024)
Journal of Nuclear Medicine (2024)
Jose Antonio Karam,Robert Uzzo,Axel Bex, William Leung, Connie Tat, Alan Nicholas, Alexander Andreev-Drakhlin,Mahrukh Huseni,Sumanta Kumar Pal,Viraj A. Master
Matthew Young,Francesca Jackson-Spence,Luis Beltran, Elizabeth Day, Christina Suarez,Axel Bex,Thomas Powles,Bernadett Szabados
Lancet (London, England) (2024)
Luna van den Brink, Daniel L. van den Kroonenberg,Niels M. Graafland,Axel Bex,Harrie P. Beerlage,Jeroen R. A. van Moorselaar,Patricia J. Zondervan
KIDNEY CANCERno. 1 (2024): 51-59
Laura Iisager, Johanne Ahrenfeldt,Frede Donskov,Börje Ljungberg,Axel Bex,Lars Lund,Iben Lyskjær,Niels Fristrup
BMC Cancerno. 1 (2024): 1-8
Jurascheck L., Fransen Van De Putte E.,Van Den Brink L.,Van Der Mijn J.C.,Wilgenhof S.,Van Thienen J.V.,Haanen J.B.A.G.,Boleti E.,Powles T.,Zondervan P.J.,Graafland N.M.,Bex A.
European Urology (2024): S1859-S1860
Nature reviews. Urologypp.1-18, (2024)
Van Den Brink L., Debelle T., Gietelink L.,Lagerveld B., Widdershoven C.V.,Graafland N.M.,Ruiter A.E.C.,Bex A.,Beerlage H.P.,Van Moorselaar R.J.A.,Zondervan P.J.
European Urology (2024): S1336
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn